Mirum Pharmaceuticals

$18.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.37 (-1.94%) Today
$0.00 (0.00%) As of 1:19 PM UTC after-hours

Why Robinhood?

You can buy or sell MIRM and other stocks, options, and ETFs commission-free!

About MIRM

Mirum Pharmaceuticals, Inc. Common Stock, also called Mirum Pharmaceuticals, is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA. The listed name for MIRM is Mirum Pharmaceuticals, Inc. Common Stock.

CEO
Christopher Peetz
Employees
33
Headquarters
Foster City, California
Founded
2018
Market Cap
542.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
140.23K
High Today
$19.27
Low Today
$18.50
Open Price
$18.91
Volume
88.68K
52 Week High
$27.43
52 Week Low
$9.14

MIRM Earnings

-$5.31
-$3.54
-$1.77
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

ISDR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure